Biosynthesis of Fatty Acids - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Biosynthesis of Fatty Acids

Description:

... in well-fed animals whose diets contains a high proportions of carbohydrates. ... conditions of restricted caloric intake, on a high-fate diet, or when there ... – PowerPoint PPT presentation

Number of Views:1408
Avg rating:3.0/5.0
Slides: 20
Provided by: DrakeRi
Category:

less

Transcript and Presenter's Notes

Title: Biosynthesis of Fatty Acids


1
Biosynthesis of Fatty Acids
  • Medical Biochemistry
  • Lecture 46

2
FattyAcids
  • Fatty acids are a class of compounds containing
    a long hydrocarbon chain and a terminal
    carboxylate group.
  • Nomenculature
  • - Systematic name for a fatty acid is derived
    from the name of its parent hydrocarbon by the
    substitution of oic for the final e.
  • - For example, the C18 saturated fatty acid
    is called octadecanoic acid (180) because the
    parent hydrocarbon is octadecane.

3
F.A. Nomenclature (cont.)
  • - C18 with one double bond is called octadecenoic
    acid (181) with two double bonds is called
    octadecadienoic acid (182) with three double
    bonds, octadecatrienoic acid (183).

4
(No Transcript)
5
Fatty acids vary in chain length and degree of
unsaturation
  •  
  • Usually contain an even number of carbon atoms,
    typically between 14 and 24. The 16- and
    18-carbon fatty acids are most common.
  •  
  • May contain one or more double bonds. The double
    bonds in polyunsaturated fatty acids are
    separated by at least one methylene group.
  •  
  • The configuration of the double bonds in most
    unsaturated fatty acids is cis.

6
Properties of fatty acids are markedly dependent
on their chain length and on the degree of
saturation.
  • -Melting point of stearic acid is 69.6oC, whereas
    that of oleic acid (with one double bond) is
    13.4oC.
  •  
  • Melting temperature of palmitic acid (C16) is
    6.5 degrees lower than that of stearic acid (C16)

7
FATTY ACID SYNTHESIS (LIPOGENESIS)
  • Glucose provides the primary substrate for
    lipogenesis 
  • In humans, adipose tissue may not be an important
    site, and liver has only low activity 
  • Variations in fatty acid synthesis between
    individuals may have a bearing on the nature and
    extent of obesity, and one of the lesions in type
    I, insulin-dependent diabetes mellitus is
    inhibition of lipogenesis
  •  
  • DE NOVO SYNTHESIS OCCURS IN CYTOSOL 
  • Liver, kidney, brain, lung, mammary gland, and
    adipose tissue.

8
Step 1 Formation of Malonylcoenzyme A is the
committed step in fatty acid synthesis It takes
place in two steps carboxylation of biotin
(involving ATP) and transfer of the carboxyl to
acetyl-CoA to form malonyl-CoA.
Reaction is catalyzed by acetyl-CoA carboxylase.
It is a multienzyme protein. The enzyme contains
a variable number of identical subunits, each
containing biotin, biotin carboxylase, biotin
carboxyl carrier protein, and transcarboxylase,
as well as a regulatory allosteric site.
9
Step 2
  • Fatty acid synthase catalyzes the remaining
    steps. It is a multienzyme polypeptide complex
    that contains acyl carrier protein (ACP). ACP
    contains the vitamin pantothenic acid in the form
    of 4'-phosphopantetheine. ACP takes over the
    role of CoA. 
  • It offers great efficiency and freedom from
    interference by competing reactions 
  • Synthesis of all enzymes in the complex is
    coordinated, since it is encoded by a single
    gene 
  • It is a dimer, and each monomer is identical,
    consisting of one chain containing all seven
    enzyme activities of fatty acid synthase and an
    ACP with a 4'-phosphopantetheine-SH group. Dimer
    is arranged in a "head to tail" configuration.
    Monomer is not active.

10
(No Transcript)
11
Step 3 Elongation of fatty acid chains occurs
in endoplasmic reticulum
  • This pathways "microsomal system" converts fatty
    acyl-CoA to an acyl-CoA derivative having two
    carbons more, using malonyl-CoA as acetyl donor
    and NADPH as reductant catalyzed by the
    microsomal fatty acid elongase system of enzymes.

12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
Nutritional state regulates lipogenesis
  • Lipogenesis converts surplus glucose and
    intermediates such as pyruvate, lactate, and
    acetyl-CoA to fat. 
  • Rate is higher in well-fed animals whose diets
    contains a high proportions of carbohydrates. 
  • It is depressed under conditions of restricted
    caloric intake, on a high-fate diet, or when
    there is a deficiency of insulin, as in diabetes
    mellitus. All these conditions are associated
    with increased concentrations of plasma free
    fatty acids. 
  • There is an inverse relationship between hepatic
    lipogenesis and the concentration of serum-free
    fatty acids. The greatest inhibition of
    lipogenesis occurs over the range of free fatty
    acids (0.3-0.8 µmol/mL pf plasma).

16
  • Fat in the diet also causes depression of
    lipogenesis in the liver, and when there is more
    than 10 of fat in the diet, there is little
    conversion of dietary carbohydrates to fat.

17
SHORT AND LONG-TERM MECHANISMS REGULATE
LIPOGENESIS
  • In the short-term, synthesis is controlled by
    allosteric and covalent modification of enzymes
    For long-term, there are changes in gene
    expression
  • Short-term
  • Acetyl-CoA carboxylase is most important in
    regulating synthesis 
  • Activated by citrate, which increases in well-fed
    state and is an indicator of a plentiful supply
    of acetyl-CoA 
  • Inhibited by long-chain acyl-CoA.  
  • Pyruvate dehydrogenase regulates availability of
    free acetyl-CoA for lipogenesis. Acetyl-CoA
    causes an inhibition of pyruvate dehyrogenase.

18
  • Hormones (short term)
  • Insulin stimulates lipogenesis by several
    mechanisms
  • a. increases transport of glucose into the cell
    (e.g., adipose tissues) and thereby increases the
    availability of both pyruvate for fatty acid
    synthesis and glycerol-3-phosphate for
    esterification of the newly formed fatty acids. 
  • b. Converts inactive form of pyruvate
    dehydrogenase to the active form in adipose
    tissues 
  • c. Activates acetyl-CoA carboxylase 
  • d. Insulin depress intracellular cAMP levels,
    inhibits lipolysis 
  • e. Insulin antagonizes the actions of glucagon
    and epinephrine

19
Long-term
  • Expression is increased in response to fed state
    and is decreased in fasting, feeding of fat, and
    in diabetes (adaptive mechanism).
Write a Comment
User Comments (0)
About PowerShow.com